123 related articles for article (PubMed ID: 11604030)
1. Polarizability fields for use in three-dimensional quantitative structure-activity relationship (3D-QSAR).
Bradley M; Waller CL
J Chem Inf Comput Sci; 2001; 41(5):1301-7. PubMed ID: 11604030
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.
Peng Y; Keenan SM; Zhang Q; Kholodovych V; Welsh WJ
J Med Chem; 2005 Mar; 48(5):1620-9. PubMed ID: 15743203
[TBL] [Abstract][Full Text] [Related]
3. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
Holder S; Lilly M; Brown ML
Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507
[TBL] [Abstract][Full Text] [Related]
4. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
5. CoMFA QSAR models of camptothecin analogues based on the distinctive SAR features of combined ABC, CD and E ring substitutions.
Virupaksha B; Alpana G
Comput Biol Med; 2012 Sep; 42(9):890-7. PubMed ID: 22840194
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR based on quantum-chemical molecular fields: toward an improved description of halogen interactions.
Güssregen S; Matter H; Hessler G; Müller M; Schmidt F; Clark T
J Chem Inf Model; 2012 Sep; 52(9):2441-53. PubMed ID: 22917472
[TBL] [Abstract][Full Text] [Related]
7. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
8. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.
Opera TI; Waller CL; Marshall GR
Drug Des Discov; 1994 Jul; 12(1):29-51. PubMed ID: 7578806
[TBL] [Abstract][Full Text] [Related]
10. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico.
Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW
J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286
[TBL] [Abstract][Full Text] [Related]
11. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
Tong L; Guo L; Lv X; Li Y
J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and complementary-receptor-field alignment rules.
Waller CL; Marshall GR
J Med Chem; 1993 Aug; 36(16):2390-403. PubMed ID: 8360884
[TBL] [Abstract][Full Text] [Related]
13. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
[TBL] [Abstract][Full Text] [Related]
14. DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein.
Gohlke H; Klebe G
J Med Chem; 2002 Sep; 45(19):4153-70. PubMed ID: 12213058
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method.
Pourbasheer E; Shokouhi Tabar S; Masand VH; Aalizadeh R; Ganjali MR
SAR QSAR Environ Res; 2015 Jun; 26(6):461-77. PubMed ID: 26055215
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bharatam PV
J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
[TBL] [Abstract][Full Text] [Related]
17. 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi.
Menezes IR; Lopes JC; Montanari CA; Oliva G; Pavão F; Castilho MS; Vieira PC; Pupo MT
J Comput Aided Mol Des; 2003; 17(5-6):277-90. PubMed ID: 14635721
[TBL] [Abstract][Full Text] [Related]
18. 3D QSAR studies on 1, 3, 4-thiadiazole derivatives: an approach to design novel anticonvulsants.
Thareja S; Aggarwal S; Verma A; Bhardwaj TR; Kumar M
Med Chem; 2010 Jul; 6(4):233-8. PubMed ID: 20843285
[TBL] [Abstract][Full Text] [Related]
19. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
Gaurav A; Singh R
Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
[TBL] [Abstract][Full Text] [Related]
20. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
